M. Weck et al.
HAr), 6.97 (d, J=2.4 Hz, 1H; HAr), 6.89 (d, J=2.6 Hz, 1H; HAr), 6.72 (d,
J=2.0 Hz, 1H; HAr), 5.72 (m, 2H; CH=CH), 3.31 (m, 2H; 2NCHCH2),
2.73–2.36 (m, 2H; CHcyclooct), 2.27–2.08 (m, 4H; CH(cyclooct)), 2.06–1.63 (m,
11H; CH, CH2(cyclooct,cyclohex)), 1.45 (m, 2H; CH2(cyclohex)), 1.41 (s, 9H; C-
MS (MALDI-TOF) calcd for (C41H58N2O4)n: m/z (%): 1285.9 (100) [M]+
(n=2), 1928.4 (68) [M]+ (n=3), 2570.9 (22) [M]+ (n=4), 3213.4 (7)
[M]+ (n=5); GPC Mn =1300, Mw =1800, PDI=1.35.
Salen oligomer 10: Salen cyclooctene ester 8 (150 mg, 0.210 mmol) and
Grubbsꢁ third-generation initiator (7.4 mg, 0.008 mmol) were used. Purifi-
cation by flash column chromatography (gradient elution: 20:1!3:1
hexane/EtOAc) afforded 133 mg of the oligomer 10 (89%) as a bright
yellow solid. TLC Rf =0.23 (5:1 hexane/EtOAc); 1H NMR (300 MHz,
CDCl3): d=13.8 (brs, 2H; OH), 8.30 (s, 1H; N=CH), 8.22 (s, 1H; N=
CH), 7.32 (d, J=2.6 Hz, 1H; HAr), 6.99 (d, J=2.4 Hz, 1H; HAr), 6.93 (d,
J=2.7 Hz, 1H; HAr), 6.77 (d, J=2.9 Hz, 1H; HAr), 5.5–5.2 (brm, 2H;
CH=CH), 4.91 (m, 1H; CHOCO), 3.33 (m, 2H; 2NCHCH2), 2.82 (m,
2H; CH2(linker)), 2.70 (m, 2H; CH2(linker)), 2.2–1.3 (m, 18H; CH, CH2(cyclooct,
(CH3)3); 13C NMR
ACHTUNGTRENNUNG(CH3)3), 1.38 (s, 9H; CAHCUTNTRGEG(NNUN CH3)3), 1.24 ppm (s, 9H; CACTHNUGTRENNGUN
(75 MHz, CDCl3): d=176.5, 165.9, 164.7, 158.0, 157.9, 141.7, 139.9, 138.4,
136.3, 130.7, 129.5, 126.9, 125.9, 122.6, 121.3, 118.2, 117.7, 72.4, 72.2, 43.2,
34.9, 34.8, 34.0, 33.1, 31.6, 31.5, 31.4, 29.5, 29.4, 29.1, 27.8, 25.9, 25.4, 24.7,
24.2 ppm; HRMS (ESI+) calcd for C41H59N2O4 [M+H]+: 643.4469;
found: 643.451.
Salen cyclooctene ester 8:[10] Salen ligand 4 (500 mg, 0.987 mmol), acid
6[35] (223 mg, 0.987 mmol), and DCC (204 mg, 0.987 mmol) were used.
Flash chromatography (gradient elution: 20:1!5:1 hexane/EtOAc) af-
forded 650 mg (92%) of the product as a bright yellow solid. TLC Rf =
cyclohex)), 1.45 (m, 2H; CH2(cyclohex)), 1.41 (s, 9H; C
ACHTUGNTRENUN(GN CH3)3), 1.38 (s, 9H; C-
1
R
ACHTUNGTRENNUNG
0.22 (10:1 hexane/EtOAc); H NMR (300 MHz, CDCl3): d=13.89 (s, 1H;
171.98, 171.6, 166.1, 164.8, 158.4, 158.2, 141.7, 140.2, 138.8, 136.6, 132–128
(2C, multiple signals HC=CH), 127.1, 126.2, 122.9, 121.5, 118.4, 117.98,
72.7, 72.4, 35.2, 35.1, 34.3, 33.5, 33.3, 31.6, 29.7, 29.5 (overlapping signals),
29.1, 28.6, 24.5, 22.5 ppm; MS (MALDI-TOF) calcd for (C44H62N2O6)n:
m/z (%): 1429.9 (100) [M]+ (n=2), 2144.4 (75) [M]+ (n=3), 2858.9 (18)
[M]+ (n=4), 3574.5 (5) [M]+ (n=5); GPC Mn =1900, Mw =2500, PDI=
1.33.
OH), 13.62 (brs, 1H; OH), 8.30 (s, 1H; N=CH), 8.22 (s, 1H; N=CH),
7.32 (d, J=2.5 Hz, 1H; HAr), 6.99 (d, J=2.5 Hz, 1H; HAr), 6.93 (d, J=
2.9 Hz, 1H; HAr), 6.78 (d, J=3.0 Hz, 1H; HAr), 5.7–5.6 (m, 2H; CH=
CH), 4.87 (m, 1H; CHOCO) 3.33 (m, 2H; 2NCHCH2), 2.81 (m, 2H;
CH2(linker)), 2.67 (m, 2H; CH2(linker)), 2.4–2.05 (m, 2H; CHcyclooct), 2.0–1.55
(m, 14H; CH, CH2(cyclooct,cyclohex)), 1.45 (m, 2H; CH2(cyclohex)), 1.42 (s, 9H;
(CH3)3); 13C NMR
CACHTUNGTRENNUNG(CH3)3), 1.39 (s, 9H; CAHCTNUTRGEG(NNUN CH3)3), 1.25 ppm (s, 9H; CACTHNUGTRENNGUN
(75 MHz, CDCl3): d=171.6, 171.59, 166.1, 164.8, 158.4, 158.1, 141.7,
140.2, 138.8, 136.6, 130.1, 129.8, 127.1, 126.2, 122.9, 121.6, 118.4, 117.98,
76.4, 72.7, 72.4, 35.2, 35.1, 34.3, 33.9, 33.8, 33.5, 33.3, 31.6, 29.7, 29.67
(overlapping signals), 29.5, 29.4, 25.7, 25.0, 24.5, 22.5 ppm; HRMS (ESI+)
calcd for C44H63N2O6 [M+H]+: 715.4681; found: 715.4639.
Salen cyclooctene ester 12: Salen ligand 11[23] (241 mg, 0.381 mmol), acid
5[10] (74 mg, 0.38 mmol), and DCC (79 mg, 0.38 mmol) were used. Flash
chromatography (20:1 hexane/EtOAc) afforded 180 mg (61%) of the
product as a bright yellow solid. TLC Rf =0.48 (10:1 hexane/EtOAc);
1H NMR (300 MHz, CDCl3): d=13.73 (s, 1H; OH), 13.72 (brs, 1H;
OH), 8.32 (s, 1H; N=CH), 8.30 (s, 1H; N=CH), 7.31 (d, J=2.4 Hz, 1H;
HAr), 7.23 (d, J=2.3 Hz, 1H; HAr), 7.00 (d, J=2.4 Hz, 1H; HAr), 6.92 (d,
J=2.2 Hz, 1H; HAr), 5.8–5.59 (m, 2H; CH=CH), 3.98 (t, J=6.6 Hz, 2H;
CH2(linker)), 3.33 (m, 2H; 2NCHCH2), 2.48–2.29 (m, 3H; CHcyclooct), 2.2–
Salen oligomer 13: Salen cyclooctene ester 12 (161 mg, 0.209 mmol) and
Grubbsꢁ third-generation initiator (7.4 mg, 0.008 mmol) were used. Purifi-
cation by flash column chromatography (gradient elution: 25:1!10:1
hexane/EtOAc) afforded 125 mg of the oligomer 13 (78%) as a bright
yellow solid. TLC Rf =0.5 (5:1 hexane/EtOAc); 1H NMR (300 MHz,
CDCl3): d=13.7 (brs, 2H; OH), 8.31 (s, 1H; N=CH), 8.30 (s, 1H; N=
CH), 7.30 (d, J=2.5 Hz, 1H; HAr), 7.22 (d, J=2.4 Hz,1H; HAr), 7.00 (d,
J=2.5 Hz, 1H; HAr), 6.91 (d, J=2.5 Hz, 1H; HAr), 5.4–5.2 (brm, 2H;
CH=CH), 4.00 (brm, 2H; CH2(linker)), 3.32 (brm, 2H; 2NCHCH2), 2.1–1.3
(m, 27H; CH, CH2(cyclooct,cyclohex,linker)), 1.40 (s, 9H; C
(CH3)3), 1.23 (s, 9H; C(CH3)3), 1.19 (s, 3H; C(CH3)2), 1.18 (s, 3H; C-
(CH3)2), 1.05 ppm (m, 2H; CH2(linker)); 13C NMR (75 MHz, CDCl3): d=
ACHTUGNTRENUN(NG CH3)3), 1.396 (s, 9H;
C
N
N
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
176.6, 166.0, 165.98, 158.2, 158.16, 140.1, 138.7, 136.6, 136.5, 130–129.5
(2C, multiple signals HC=CH), 127.3, 126.94, 126.9, 126.3, 118.1, 118.07,
72.6, 72.58, 64.6, 44.5, 45.3–43.2 (1C, multiple signals CHCO2), 37.2 (over-
lapping signals), 35.2, 35.16, 34.2, 33.6, 33.55, 31.6 (overlapping signals),
30.1, 29.7, 29.65, 29.2, 29.1, 28.9, 28.1, 26.0, 25.97, 24.8 (overlapping sig-
nals), 24.6 ppm (overlapping signals); MS (MALDI-TOF) calcd for
(C50H76N2O4)n: m/z (%): 1538.3 (100) [M]+ (n=2), 2306.9 (67) [M]+
(n=3), 3076.6 (15) [M]+ (n=4), 3844.3 (3) [M]+ (n=5); GPC Mn=1850,
Mw =2600, PDI=1.39.
1.43 (m, 24H; CH, CH2(cyclooct,cyclohex,linker)), 1.41 (s, 9H; C
9H; C(CH3)3), 1.24 (s, 9H; C(CH3)3), 1.2 (s, 3H; C(CH3)2), 1.19 (s, 3H;
(CH3)2), 1.05 ppm (m, 2H; CH2(linker)); 13C NMR (75 MHz, CDCl3): d=
ACHTUGNTREN(UNNG CH3)3), 1.40 (s,
A
R
ACHTUNGTRENNUNG
CACHTUNGTRENNUNG
178.0, 166.0, 165.99, 158.2, 158.16, 140.1, 138.7, 136.6, 136.5, 130.7, 129.8,
127.3, 126.95, 126.91, 126.3, 118.1, 118.08, 72.6, 72.59, 64.6, 44.5, 43.7,
37.3, 37.2, 35.2, 35.1, 34.3, 33.6, 33.5, 31.9, 31.6, 30.1, 29.7, 29.6, 29.2,
29.17, 28.9, 28.1, 26.1, 25.97, 24.7, 24.6 (overlapping signals), 24.4 ppm;
HRMS (ESI+) calcd for C50H77N2O4 [M+H]+: 769.5878; found: 769.5882.
General procedure for the metalation of oligomeric salen: A solution of
the oligomer (1 equiv) in CH2Cl2 (0.16m) were added to a flame dried
Schlenk flask (10 mL) equipped with a magnetic stirrer bar in an atmos-
phere of argon. A solution of diethyl aluminum chloride in toluene
(1.8m, 1 equiv) was added slowly to the reaction flask. The reaction mix-
ture was allowed to stir for 3 h, following which the solvents were re-
moved in vacuo to afford a yellow solid. The resultant solid was rinsed
with hexane (3ꢃ1.5 mL) and dried to afford the metalated oligomeric
catalyst.
General procedure for the synthesis of macrocyclic oligomeric salen: In a
scintillation vial equipped with a magnetic stir bar, a solution of Grubbsꢁ
third-generation initiator (0.04 equiv) in deoxygenated CH2Cl2 was added
to a solution of monomer (1 equiv) in deoxygenated CH2Cl2 (final solu-
tion concentration 0.1m with respect to monomer). The reaction mixture
was stirred at RT for 30 min, followed by the addition of a few drops of
ethyl vinyl ether to quench the reaction. The reaction mixture was con-
centrated in vacuo and the resultant residue was purified by flash column
chromatography to obtain the pure oligomeric product.
Salen oligomer 9:[10] Salen cyclooctene ester 7 (161 mg, 0.25 mmol) and
Grubbsꢁ third generation initiator (8.8 mg, 0.01 mmol) were used. Purifi-
cation by flash column chromatography (gradient elution: 25:1!10:1
hexane/EtOAc) afforded 117 mg of the oligomer 9 (73%) as a bright
yellow solid. TLC Rf =0.46 (5:1 hexane/EtOAc); 1H NMR (300 MHz,
CDCl3): d=13.89 (s, 1H; OH), 13.63 (brs, 1H; OH), 8.30 (s, 1H; N=
CH), 8.24 (s, 1H; N=CH), 7.31 (d, J=1.0 Hz, 1H; HAr), 6.98 (d, J=
2.1 Hz, 1H; HAr), 6.89 (s, 1H; HAr), 6.74 (s, 1H; HAr), 5.6–5.3 (brm, 2H;
CH=CH), 3.31 (brm, 2H; 2NCHCH2), 2.53 (brm, 1H; CHCO2), 2.4–1.4
Oligomeric catalyst 1: Oligomer 9 (100 mg, 0.156 mmol) and a solution
of diethyl aluminum chloride in toluene (86.0 mL, 0.155 mmol) were
used to afford 108 mg of catalyst 1 (99%) as a bright yellow solid.
1H NMR (300 MHz, CDCl3): d=8.33 (brs, 1H; N=CH), 8.30 (brs, 1H;
N=CH), 7.56 (s, 1H; HAr), 7.13 (s, 1H; HAr), 7.09 (s, 1H; HAr), 6.97 (s,
1H; HAr), 5.6–5.3 (brm, 2H; CH=CH), 3.74 (brm, 1H; NCHCH2), 3.09
(brm, 1H; NCHCH2), 2.53 (brm, 1H; CHCO2), 2.8–1.3 (m, 18H; CH,
CH2(cyclooct, cyclohex)), 1.53 (brs, 18H; 2CACHTNUGTRENN(UG CH3)3), 1.31 ppm (s, 9H; CACHTUNGTRENNUNG(CH3)3);
13C NMR (75 MHz, CDCl3): d=175.3, 167.1, 164.7, 158.8, 158.5, 141.1,
140.7, 138.8 (overlapping signals), 132.5–129.7 (2C, multiple signals HC=
CH) , 128.3, 126.6, 123.1 (overlapping signals), 118.6 (overlapping sig-
nals), 72.7 (overlapping signals), 45.3–43.2 (1C, multiple signals CHCO2),
35.8, 35.4, 34.2, 33.5, 32.6 (overlapping signals), 31.6, 30.8–30.2 (m), 29.9,
29.7, 27.6–26.8 (m), 25.5, 23.8 ppm; ICP calcd (%): Al 3.8; found: Al 4.7.
(m, 18H; CH, CH2(cyclooct,cyclohex)), 1.40 (s, 9H; CACHTUNGTRNEN(UNG CH3)3), 1.39 (s, 9H; C-
A
ACHTUNGTRENNUNG
175.2, 166.1, 164.8, 158.3, 158.1, 141.7, 140.1, 138.7, 136.6, 132.5–128.7
(2C, multiple signals HC=CH), 127.1, 126.2, 122.9, 121.5, 118.4, 117.96,
72.7, 72.3, 45.3–43.2 (1C, multiple signals CHCO2), 35.2, 35.1, 34.2, 33.5,
33.4, 32.1, 31.6, 30.8–30.2 (m), 29.7, 29.3, 27.6–26.8 (m), 24.5, 24.2 ppm;
Oligomeric catalyst 2: Oligomer 10 (110 mg, 0.154 mmol) and a solution
of diethyl aluminum chloride in toluene (86.0 mL, 0.155 mmol) were used
1192
ꢀ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2009, 15, 1186 – 1194